TrialCancer immunology, immunotherapy : CII2011

Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up.

Benjamin Weide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.